Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

Phillips-Medisize has announced  that it is expanding its current Global Innovation and Development (GID) site in Struer, Denmark, to include a dedicated manufacturing development and clinical build unit.


Phillips-Medisize Grows Clinical Manufacturing Capabilities to Meet Demand

Catalent completes purchase of biologics fill-finish and oral solid dose facility in Anagni, Italy

Catalent Expands Fill-Finish Capacity

Catalent’s planning service is designed to assist in evaluating needs for launching and maintaining clinical trials. 

Catalent Announces Clinical Trial Planning Service

The acquisition expands Charles River’s scientific capabilities in cell therapy development.

Charles River Laboratories to Acquire HemaCare in $380-Million Deal

Cambrex reports that the acquisition by the investment group will facilitate ongoing growth.

Cambrex Sale to Premira Funds Affiliate Closes

Catalent and Ethicann Pharmaceuticals have announced a partnership aimed at developing a new combination pharmaceutical-grade CBD and THC product to treat MS spasticity using Catalent’s orally disintegrating tablet technology.


Catalent, Ethicann Partner on Fast-Dissolve Cannabinoid Treatment for MS Spasticity

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Spray drying is a versatile and rapid technique that can provide companies with a suitable and scalable option to improve the solubility and bioavailability of drug products.


Tackling Solubility in Drug Development

As regulatory bodies extend the oversight of E&L testing, companies working with drug products need to make provisions on how to best comply with the evolving expectations.


Meeting E&L Expectations

The companies announced a commercial supply agreement following FDA’s accelerated approval.

Catalent to Supply BeiGene’s Brukinsa

New training facilities, laboratories, packaging, gene therapy manufacturing, and biologics manufacturing highlight Thermo Fisher Scientific expansions.